BioSante (Nasdaq: BPAX) is indicated to open 40% higher after reporting positive LibiGel safety data from its Phase III clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE